KORAD (Korea Radioactive Waste Agency, http://www.korad.or.kr) has stored slightly contaminated ascon (asphalt coated concrete mixture) that was introduced to Gyeongju repository about a decade ago waiting for a final disposal. It is believed to be mainly contaminated by radioisotope 137Cs due to impurities introduced from the outside during the ascon manufacturing process. We studied characteristics of the radioactive waste to see whether this material would be proper enough to be disposed in Gyeongju LILW repository or be other ways to reduce the disposal volume including self-disposal before its final disposal otherwise. KORAD looked into the properness of characteristics of ascon in terms of WAC (Waste Acceptance Criteria) documented by KORAD that includes general chemical and physical properties of asphalt, density, size of grains, content of organic material and possibility of existence of chelate materials that qualitatively limited to be disposed by the criteria. And other associated characteristics such as gas generation and bio degradation were also investigated. Based on the data obtained from the study, we proposed various plausible solutions in associated with operational and disposal safety and economic view points. This study will be used for KORAD’s decision on how to control and safely dispose the spent ascon within a reasonable time period. And also those experiences may be applied for other LILW issues that require treatment or conditioning of radioactive wastes in the future.

We report a massive outbreak of human Q fever cases, which occurred at totally 11 humans. The occurrence was related to a goat farm where Coxiella burnetii infection was diagnosed from goat tissues and environmental specimens. From January of 2018, continuous abortions from 6 goats occurred. Laboratory tests from 77 goat specimens for C. burnetii showed that 54 (70.1%) and 63 (81.8%) goats were positive by polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA), respectively. The infection was also confirmed from the farmer, his wife and 9 persons from all 16 veterinary officials who had visited the farm for protective measures and preparing goat specimens for laboratory tests. The farm was found to be extensively contaminated with C. burnetii from the examination to the environmental specimens and epidemiological inspections, which might be the main source of C. burnetii infection to humans. The extensive contamination to the farm was derived from the uncareful handling of postpartum animal tissues or discharges by the farm owner. This report will contribute to the establishment of educational system on the biosecurity to novice farmers.

Pseudomembranous colitis (PMC) is known to be associated with the long-term administration of antibiotics, which alter normal gastrointestinal flora and allow overgrowth of Clostridium difficile. However, antituberculosis agents are rarely reported as a cause of this disease. Besides, most cases of antituberculosis agent-induced PMC have been observed in patients with pulmonary tuberculosis but not with tuberculous meningitis. This report presents a case of PMC associated with antituberculosis therapy in a patient with tuberculous meningitis. A 29-year-old female patient was admitted due to headaches and diplopia that had lasted for 2 weeks. She had not recently received antimicrobial therapy. She was diagnosed with tuberculous meningitis by cerebrospinal fluid findings and neurologic examination, including brain imaging study. She was treated with standard antituberculosis agents (HERZ regimen: isoniazid, ethambutol, rifampicin, and pyrazinamide). After 11 days of HERZ, she developed a fever, sudden widespread skin eruption, and elevation of liver enzymes. Considering adverse drug reactions, antituberculosis agents were stopped. One week later, her symptoms were relieved. Thus, antituberculosis agents were reintroduced one at a time after liver function returned to normal. However, she presented with frequent mucoid, jelly-like diarrhea, and lower abdominal pain. Sigmoidscopy revealed multiple yellowish plaques with edematous mucosa, which were compatible with PMC. She was treated with oral vancomycin considering drug interactions. Symptoms were relieved and did not recur when all antituberculosis agents except pyrazinamide were started again. Therefore, when a patient complains of abdominal pain or diarrhea after initiation of antituberculosis therapy, the physician should consider the possibility of antituberculosis agent-associated PMC.